Massive Bio, Inc.
Medical device company · New York, United States
Massive Bio, Inc. is a medical device company headquartered in New York, United States. Its earliest recorded incorporation is in 2015. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $399,594 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $2.5 million sold in a notice filed in 2019.
Massive Bio at a glance
What does Massive Bio do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $399,594 in total (2020).
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.5 million sold (2019).
Frequently asked questions about Massive Bio
Where is Massive Bio headquartered?
Massive Bio, Inc. is headquartered in New York, United States.
What does Massive Bio do?
Massive Bio, Inc. is a medical device company.
When was Massive Bio founded?
The earliest incorporation on record for Massive Bio, Inc. is in 2015, according to public company registers.
Similar companies
- PAVmed Inc.New York City, New York, United States
- Lucid Diagnostics Inc.New York City, New York, United States
- Intelligent Bio Solutions Inc.New York City, New York, United States
- Fisher Wallace Laboratories, Inc.New York City, New York, United States
- Microstructure Imaging, Inc.New York City, New York, United States
- Addinex Technologies, Inc.New York City, New York, United States
- Spark Neuro Inc.New York City, New York, United States
- Hyprevention Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences